Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Single Nucleotide Polymorphism (SNP) represents the most common type of mutation in genomes of all life forms. SNP genotyping is the measurement of genetic variations of SNPs between members of a species.

The global SNP genotyping and analysis market is estimated to account for US$ 11,553.0 Mn in terms of value in 2020 and is expected to reach US$ 46,268.9 Mn by the end of 2027.

Global SNP Genotyping and Analysis Market: Drivers

Increasing prevalence of genetic disorders is expected to propel growth of the global SNP genotyping and analysis market over the forecast period. For instance, according to Summary of the Cystic Fibrosis Foundation Patient Registry, 2003–2018, the number of people with cystic fibrosis increased from 21,421 in 2003 to 30,775 in 2018.

Moreover, collaborative efforts to enhance personalized medicine is also expected to aid in growth of the market. For instance, in April 2020, Indivumed GmbH, an oncology company, launched the Oncology Alliance for Individualized Medicine, an international collaborative alliance to advance personalized medicine in cancer through IndivuType, the company’s multi-omics database.

SNP Microarray held dominant position in the global SNP genotyping and analysis market in 2019, accounting for 37.9% share in terms of value, followed by Taqman Allelic Discrimination and Others, respectively.

Figure 1. Global SNP Genotyping and Analysis Market Share (%), by Value, by Technology, 2019

SNP Genotyping and Analysis  | Coherent Market Insights

Global SNP Genotyping and Analysis Market: Restraints

Imperfect protocols leading to large redundant data are expected to hinder growth of the market. Several areas such as diagnostics within the genotyping segment are currently yet to reveal themselves as potential markets. Although diagnostics has been closely associated with SNP genotyping, currently the genotyping technique only serves as a research tool in diagnostics instead of being able to conduct a diagnostic test.

Moreover, despite the high accuracy of short read sequencing, there are still issues with attaining accurate SNP genotypes at low sequencing coverage and in highly duplicated genomes due to misalignment, which is also expected to limit growth of the market.

request-sample

SNP Genotyping and Analysis Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 9,485.2 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 21.9% 2027 Value Projection: US$ 46,268.9 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: South Africa, North Africa, Central Africa
Segments covered:
  • By Technology: SNP Microarray, Taqman Allelic Discrimination, SNP Pyrosequencing Technologies, ABISNPlex, Sequenom Mass-Array MALDI-TOF, Others.
  • By Application: Pharmaceuticals and Pharmacogenomics, Diagnostic Research, Agricultural Biotechnology, Breeding and Animal Livestock.
Companies covered:

LGC Limited, Fluidigm Corporation, Illumina, Inc., Life Technologies Corporation, PREMIER Biosoft, Thermo Fisher Scientific, and Sequenom, Inc.

Growth Drivers:
  • Increasing prevalence of genetic disorders
  • Technological advancement
Restraints & Challenges:
  • Lack of evidences associated with the treatment coronavirus disease (COVID 19)

Global SNP Genotyping and Analysis Market: Opportunities 

Increasing adoption of SNP genotyping in farm animal gene exploration is expected to offer lucrative growth opportunities for players in the global SNP genotyping and analysis market. For instance, in April 2020, researchers from Jung P & C Institute, Inc., South Korea, used Bayesian methods under different genotyping platforms to perform genomic analysis in Korean Duroc pigs.

Moreover, genomic, retrospective, multicenter analysis of cancer is also expected to aid in growth of the market. For instance, in June 2020, a study presented via the virtual Society of Gynecologic Oncology 2020 Annual Meeting on Women's Cancer, reported examining a large clinical dataset of low-grade serous ovarian cancer through the Ovarian Cancer Association Consortium, with the primary goal of identifying factors that affect survival.

The global SNP genotyping and analysis market was valued at US$ 9,485.2 Mn in 2019 and is forecast to reach a value of US$ 46,268.9 Mn by 2027 at a CAGR of 21.9% between 2020 and 2027.

Figure 2. Global SNP Genotyping and Analysis Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

SNP Genotyping and Analysis  | Coherent Market Insights

Market Trends/Key Takeaways

Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in February 2020, Fluidigm Corporation acquired InstruNor AS, a privately held provider of fully integrated sample preparation system for flow and mass cytometry.

Major players in the market are focused on investing in targeted therapies. For instance, in October 2018, Thermo Fisher Scientific facilitated the next phase of the FinnGen precision medicine study that aims to deepen the overall understanding of chronic disease mechanisms in the Finnish population.

Global SNP Genotyping and Analysis Market: Competitive Landscape

Major players operating in the global SNP genotyping and analysis market include, LGC Limited, Fluidigm Corporation, Illumina, Inc., Life Technologies Corporation, PREMIER Biosoft, Thermo Fisher Scientific, and Sequenom, Inc.

Global SNP Genotyping and Analysis Market: Key Developments

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in July 2019, Thermo Fisher Scientific launched three new Applied Biosystems AgriSeq targeted genotyping by sequencing solutions that will allow customers to genotype canines and felines.

Genotyping refers to determining differences in the genetic make-up by analyzing DNA sequences of individuals. Genotyping has wide variety of applications ranging from drug discovery to disease diagnosis. Genetic diseases (which have different genetic make ups in certain places in DNA) can be identified and diagnosed by comparing those sequences with the reference sequences. 

Restraints of the Global SNP Genotyping and Analysis Market

Major factors hampering the growth of the SNP genotyping and analysis market during the forecast period constitutes of imperfect protocols leading to large redundant data, and high costs of devices.

Key features of the study:

  • This report provides in-depth analysis of the global SNP genotyping and analysis market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global SNP genotyping and analysis market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include LGC Limited, Fluidigm Corporation, Illumina, Inc., Life Technologies Corporation, PREMIER Biosoft, Thermo Fisher Scientific, and Sequenom, Inc.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global SNP genotyping and analysis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global SNP Genotyping and Analysis Market, By Technology:
    • SNP Microarray
    • Taqman Allelic Discrimination
    • SNP Pyrosequencing Technologies
    • ABISNPlex
    • Sequenom Mass-Array MALDI-TOF
    • Others
  • Global SNP Genotyping and Analysis Market, By Application:
    • Pharmaceuticals and Pharmacogenomics
    • Diagnostic Research
    • Agricultural Biotechnology
    • Breeding and Animal Livestock
  • Global SNP Genotyping and Analysis Market, By Geography:
    • North America
      • By Technology
        • SNP Microarray
        • Taqman Allelic Discrimination
        • SNP Pyrosequencing Technologies
        • ABISNPlex
        • Sequenom Mass-Array MALDI-TOF
        • Others
      • By Application
        • Pharmaceuticals and Pharmacogenomics
        • Diagnostic Research
        • Agricultural Biotechnology
        • Breeding and Animal Livestock
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Technology
        • SNP Microarray
        • Taqman Allelic Discrimination
        • SNP Pyrosequencing Technologies
        • ABISNPlex
        • Sequenom Mass-Array MALDI-TOF
        • Others
      • By Application
        • Pharmaceuticals and Pharmacogenomics
        • Diagnostic Research
        • Agricultural Biotechnology
        • Breeding and Animal Livestock
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Technology
        • SNP Microarray
        • Taqman Allelic Discrimination
        • SNP Pyrosequencing Technologies
        • ABISNPlex
        • Sequenom Mass-Array MALDI-TOF
        • Others
      • By Application
        • Pharmaceuticals and Pharmacogenomics
        • Diagnostic Research
        • Agricultural Biotechnology
        • Breeding and Animal Livestock
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Technology
        • SNP Microarray
        • Taqman Allelic Discrimination
        • SNP Pyrosequencing Technologies
        • ABISNPlex
        • Sequenom Mass-Array MALDI-TOF
        • Others
      • By Application
        • Pharmaceuticals and Pharmacogenomics
        • Diagnostic Research
        • Agricultural Biotechnology
        • Breeding and Animal Livestock
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East:
      • By Technology
        • SNP Microarray
        • Taqman Allelic Discrimination
        • SNP Pyrosequencing Technologies
        • ABISNPlex
        • Sequenom Mass-Array MALDI-TOF
        • Others
      • By Application
        • Pharmaceuticals and Pharmacogenomics
        • Diagnostic Research
        • Agricultural Biotechnology
        • Breeding and Animal Livestock
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Technology
        • SNP Microarray
        • Taqman Allelic Discrimination
        • SNP Pyrosequencing Technologies
        • ABISNPlex
        • Sequenom Mass-Array MALDI-TOF
        • Others
      • By Application
        • Pharmaceuticals and Pharmacogenomics
        • Diagnostic Research
        • Agricultural Biotechnology
        • Breeding and Animal Livestock
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • LGC Limited *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Fluidigm Corporation
    • Illumina, Inc.
    • Life Technologies Corporation
    • PREMIER Biosoft
    • Thermo Fisher Scientific
    • Sequenom, Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technology
      • Market Snippet, By Application
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
    • COVID-19 Impact Analysis
  4. Global SNP Genotyping and Analysis Market, By Technology, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • SNP Microarray
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Taqman Allelic Discrimination
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • SNP Pyrosequencing Technologies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • ABISNPlex
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Sequenom Mass-Array MALDI-TOF
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
  5. Global SNP Genotyping and Analysis Market, By Application, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Pharmaceuticals and Pharmacogenomics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Diagnostic Research
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Agricultural Biotechnology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Breeding and Animal Livestock
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global SNP Genotyping and Analysis Market, By Regions, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Company Profiles
      • LGC Limited
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Fluidigm Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Illumina, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Life Technologies Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • PREMIER Biosoft
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Thermo Fisher Scientific
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Sequenom, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 25 figures on “SNP Genotyping and Analysis Market – Global forecast to 2027.

Frequently Asked Questions

The global SNP genotyping and analysis market was valued at US$ 9,485.2 Mn in 2019 and is forecast to reach a value of US$ 46,268.9 Mn by 2027 at a CAGR of 21.9% between 2020 and 2027.
Major factor driving the growth of global SNP genotyping and analysis market during the forecast period include increasing prevalence of genetic disorders, and technological advancement.
Major factors hampering the growth of the SNP genotyping and analysis market during the forecast period constitutes of imperfect protocols leading to large redundant data, and high costs of devices.
SNP Microarray held dominant position in the global SNP genotyping and analysis market in 2019.
North America SNP Genotyping and Analysis market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are LGC Limited, Fluidigm Corporation, Illumina, Inc., Life Technologies Corporation, PREMIER Biosoft, Thermo Fisher Scientific, and Sequenom, Inc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner